# 2020 discharge: European Medicines Agency (EMA)

European Parliament procedure 2021/2132(DEC) (DEC - Discharge procedure, 9th term, committee ENVI). Stage: Procedure completed. 20 committee amendments tabled by 5 Members between 2021-12-08 and 2021-12-08.

## What the amendments focus on

A discharge decision on the European Medicines Agency for the financial year 2020. The amendments emphasise the EMA's role in assessing the quality, safety and efficacy of medicines, the impact of the COVID-19 pandemic, transparency and independence given largely private funding, fee waivers for COVID-19 and orphan medicines, the relocation to Amsterdam after the United Kingdom's withdrawal, staff shortages and the proposed mandate extension, medicine shortages, and antimicrobial resistance.

## Most active Members on this file

| Member | Country | Group | Amendments | Markdown |
|---|---|---|---|---|
| Michèle RIVASI | France | Verts/ALE | 6 | https://amendeu.com/md/meps/96743.md |
| Stanislav POLČÁK | Czechia | PPE | 5 | https://amendeu.com/md/meps/124704.md |
| Monika BEŇOVÁ | Slovakia | NI | 4 | https://amendeu.com/md/meps/23868.md |
| Alexandr VONDRA | Czechia | ECR | 4 | https://amendeu.com/md/meps/197537.md |
| Nathalie COLIN-OESTERLÉ | France | PPE | 1 | https://amendeu.com/md/meps/197536.md |

## Official source documents

- PE700.624: https://www.europarl.europa.eu/doceo/document/ENVI-AM-700624_EN.pdf

Full amendment texts, votes and exports: https://amendeu.com/dossiers/2021-2132-DEC · machine-readable: https://amendeu.com/data/dossiers/2021-2132-DEC.json

---

Source: AmendEU (amendeu.com), built from Parltrack (ODbL), European Parliament Open Data ((c) European Union) and official Parliament documents. Aggregates CC BY 4.0.
Data refreshed: 2026-07-27. Human-readable version: https://amendeu.com/dossiers/2021-2132-DEC
When citing, attribute to "AmendEU (amendeu.com)".